6 Podcast Episodes
Immune Function in CLL: What is Wrong and Why? - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
Immune Function in CLL: What is Wrong and Why? - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
Positioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease
31 Dec 2019
•
30mins
CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
Positioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease
31 Dec 2019
•
49mins
CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
Positioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease
31 Dec 2019
•
49mins
Immune Function in CLL: What is Wrong and Why? - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
Immune Function in CLL: What is Wrong and Why? - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
Positioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease
31 Dec 2019
•
30mins
CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
First- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy
31 Dec 2019
•
49mins
CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
CLL Case Discussions - Richard R. Furman, MD; Jennifer R. Brown, MD, PhD; Matt S. Davids, MD, MMSc; Neil E. Kay, MD; Kanti R. Rai, MD
First- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy
31 Dec 2019
•
49mins